Infliximab Treatment in Resistant Pyoderma Gangrenosum: A Case Report.
Pyoderma gangrenosum (PG) is an uncommon neutrophilic dermatosis consisting of nodules and pustules that ulcerate. Pyoderma gangrenosum is associated with autoimmune disorders such as inflammatory bowel disease, spondyloarthritis, and rheumatoid arthritis. In mild disease, therapy consists of local...
| Published in: | Turkish Journal of Physical Medicine & Rehabilitation / Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi Vol. 58; no. 4; pp. 332 - 335 |
|---|---|
| Main Authors: | , , , |
| Format: | case study pictorial tables/charts Journal Article |
| Published: |
Turkish Society of Physical Medicine & Rehabilitation
Dec2012
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104296798&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104296798 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13020234 31X3 jtl: Turkish Journal of Physical Medicine & Rehabilitation / Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi issn: 13020234 maglogo: N pubinfo: dt: Dec2012 vid: 58 iid: 4 pid: 41374 pub: Turkish Society of Physical Medicine & Rehabilitation artinfo: ui: 104296798 85029142 10.4274/tftr.43760 104296798 ppf: 332 ppct: 3 formats: tig: atl: Infliximab Treatment in Resistant Pyoderma Gangrenosum: A Case Report. aug: au: Durmaz, Yunus BİLgİCİ, Ayhan CİL, Erhan Erdem Kuru, Ãmer affil: Ondokuz Mayıs University, Department of Physical Medicine and Rehabilitation, Samsun, Turkey sug: subj: Pyoderma Gangrenosum Drug Therapy Infliximab Therapeutic Use Drug Resistance Comorbidity Treatment Outcomes Pyoderma Gangrenosum Diagnosis Adult Male Adult: 19-44 years Male ab: Pyoderma gangrenosum (PG) is an uncommon neutrophilic dermatosis consisting of nodules and pustules that ulcerate. Pyoderma gangrenosum is associated with autoimmune disorders such as inflammatory bowel disease, spondyloarthritis, and rheumatoid arthritis. In mild disease, therapy consists of local wound care and topical or intralesional corticosteroids. For more severe disease, systemic agents are necessary. Herein, we present the case of a patient with steroid resistant pyederma gangrenosum associated with ulcerative colitis and ankylosing spondylitis who responded well to infliximab, a tumor necrosis factor blocker. Biological agents (anti-TNF) may be alternative treatment options in patients with resistant PG. pubtype: Academic Journal doctype: case study pictorial tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|